MDV3100 (enzalutamide)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MDV3100 (enzalutamide), covering 2013-07-30 to 2024-11-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients [Phase 1, Phase 2]